A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical-chemical risk factors of cardiovascular disease in a primary care setting. [electronic resource]
Producer: 20010816Description: 857-63 p. digitalISSN:- 0031-6970
- Adult
- Aged
- Apolipoproteins A -- blood
- Cardiovascular Diseases -- etiology
- Cholesterol, LDL -- blood
- Double-Blind Method
- Female
- Glutamine -- therapeutic use
- Humans
- Hypercholesterolemia -- complications
- Hypolipidemic Agents -- therapeutic use
- Male
- Middle Aged
- Netherlands
- Pyridoxal Phosphate -- therapeutic use
- Reference Values
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.